Eric L Sievers

This profile gathers the share dealings of Eric L Sievers in Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.). The record holds 5 filings, for trades running from 1 April 2015 to 28 August 2017.

No open-market sale appears; the market trades are 4 purchases worth €275k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2017: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €57k. No cluster: in 4 purchases, no other insider of the company bought within 30 days.

Most recently, on 31 August 2017, the filings show an open-market purchase worth €33k in Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.). Typically, a trade is published a median of 2 days after it takes place. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.